QUANTIFYING ONCOGENIC PHOSPHOTYROSINE SIGNALING NETWORKS THROUGH SYSTEMS BIOLOGY

Por Del Rosario, Amanda M., White, Forest M.
Publicado em 2010

Ligand Binding and Circular Permutation Modify Residue Interaction Network in DHFR

Por Hu, Zengjian, Bowen, Donnell, Southerland, William M, del Sol, Antonio, Pan, Yongping, Nussinov, Ruth, Ma, Buyong
Publicado em 2007

JAMI: a Java library for molecular interactions and data interoperability

Por Sivade (Dumousseau), M., Koch, M., Shrivastava, A., Alonso-López, D., De Las Rivas, J., del-Toro, N., Combe, C. W., Meldal, B. H. M., Heimbach, J., Rappsilber, J., Sullivan, J., Yehudi, Y., Orchard, S.
Publicado no BMC Bioinformatics (2018)

JAMI: a Java library for molecular interactions and data interoperability

Por M. Sivade (Dumousseau), M. Koch, A. Shrivastava, D. Alonso-López, J. De Las Rivas, N. del-Toro, C. W. Combe, B. H. M. Meldal, J. Heimbach, J. Rappsilber, J. Sullivan, Y. Yehudi, S. Orchard
Publicado em 2018-04-01

Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know

Por Couñago, Felipe, Sancho, Gemma, Catalá, Violeta, Hernández, Diana, Recio, Manuel, Montemuiño, Sara, Hernández, Jhonathan Alejandro, Maldonado, Antonio, del Cerro, Elia
Publicado no World J Clin Oncol (2017)

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

Por Hjorth-Hansen, Henrik, Stenke, Leif, Söderlund, Stina, Dreimane, Arta, Ehrencrona, Hans, Gedde-Dahl, Tobias, Gjertsen, Bjørn Tore, Höglund, Martin, Koskenvesa, Perttu, Lotfi, Kourosh, Majeed, Waleed, Markevärn, Berit, Ohm, Lotta, Olsson-Strömberg, Ulla, Remes, Kari, Suominen, Merja, Simonsson, Bengt, Porkka, Kimmo, Mustjoki, Satu, Richter, Johan
Publicado no Eur J Haematol (2015)

High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 “ISTAHIT” study

Por Petzer, Andreas L., Wolf, Dominik, Fong, Dominic, Lion, Thomas, Dyagil, Irina, Masliak, Zvenyslava, Bogdanovic, Andrija, Griskevicius, Laimonas, Lejniece, Sandra, Goranov, Stefan, Gercheva, Liana, Stojanovic, Aleksandar, Peytchev, Dontcho, Tzvetkov, Nikolay, Griniute, Rasa, Oucheva, Radka, Ulmer, Hanno, Kwakkelstein, Marthin, Rancati, Francesca, Gastl, Guenther
Publicado em 2010

Detection of derivative 9 deletion by BCR-ABL fluorescence in-situ hybridization signal pattern to evaluate treatment response in CML patients

Por Bakshi Sonal R., Shah Pankaj M., Shukla Shilin N., Dalal Esha N., Iyer Ramesh R., Brahmbhatt Manisha M., Gajjar Sarju B., Trivedi Pina J., Patel Beena P.
Publicado em 2009-01-01

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

Por Issa, Ghayas C., Kantarjian, Hagop M., Gonzalez, Graciela Nogueras, Borthakur, Gautam, Tang, Guilin, Wierda, William, Sasaki, Koji, Short, Nicholas J., Ravandi, Farhad, Kadia, Tapan, Patel, Keyur, Luthra, Raja, Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Rios, Mary Beth, Dellasala, Sara, Jabbour, Elias, Cortes, Jorge E.
Publicado no Blood (2017)

Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI

Por Copelan, Edward A., Avalos, Belinda, Ahn, Kwang Woo, Zhu, Xiaochun, Gale, Robert Peter, Grunwald, Michael R., Hamadani, Mehdi, Hamilton, Betty K., Hale, Gregory A., Marks, David I., Waller, Edmund K., Savani, Bipin N., Costa, Luciano J., Ramanathan, Muthalagu, Cahn, Jean-Yves, Khoury, H. Jean, Weisdorf, Daniel J., Inamoto, Yoshihiro, Kamble, Rammurti T., Schouten, Harry C., Wirk, Baldeep, Litzow, Mark R., Aljurf, Mahmoud D., van Besien, Koen W., Ustun, Celalettin, Bolwell, Brian J., Bredeson, Christopher N., Fasan, Omotayo, Ghosh, Nilanjan, Horowitz, Mary M., Arora, Mukta, Szer, Jeffrey, Loren, Alison W., Alyea, Edwin P., Cortes, Jorge, Maziarz, Richard T., Kalaycio, Matt E., Saber, Wael
Publicado no Biol Blood Marrow Transplant (2014)

RegulonDB v8.0: omics data sets, evolutionary conservation, regulatory phrases, cross-validated gold standards and more

Por Salgado, Heladia, Peralta-Gil, Martin, Gama-Castro, Socorro, Santos-Zavaleta, Alberto, Muñiz-Rascado, Luis, García-Sotelo, Jair S., Weiss, Verena, Solano-Lira, Hilda, Martínez-Flores, Irma, Medina-Rivera, Alejandra, Salgado-Osorio, Gerardo, Alquicira-Hernández, Shirley, Alquicira-Hernández, Kevin, López-Fuentes, Alejandra, Porrón-Sotelo, Liliana, Huerta, Araceli M., Bonavides-Martínez, César, Balderas-Martínez, Yalbi I., Pannier, Lucia, Olvera, Maricela, Labastida, Aurora, Jiménez-Jacinto, Verónica, Vega-Alvarado, Leticia, del Moral-Chávez, Victor, Hernández-Alvarez, Alfredo, Morett, Enrique, Collado-Vides, Julio
Publicado em 2013

Cognitive and linguistic aspects of geographic space new perspectives on geographic information research /

Por Raubal, Martin., Mark, David M., Frank, Andrew U.
Publicado em 2013

The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells

Por Pellicano, Francesca, Šimara, Pavel, Sinclair, Amy, Helgason, G. Vignir, Copland, Mhairi, Grant, Steven, Holyoake, Tessa Laurie
Publicado em 2011

Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors

Por Wang, Wei, Cortes, Jorge E., Lin, Pei, Beaty, Michael W., Ai, Di, Amin, Hesham M., McDonnell, Timothy J., Ok, Chi Young, Kantarjian, Hagop M., Medeiros, L. Jeffrey, Hu, Shimin
Publicado no Blood (2015)

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score...

Por Chhikara, Sunita, Sazawal, Sudha, Singh, Kanwaljeet, Chaubey, Rekha, Pati, Haraprasad, Tyagi, Seema, Mahapatra, Manoranjan, Saxena, Renu
Publicado no South Asian J Cancer (2018)

Significance Analysis of Microarrays (SAM) Offers Clues to Differences Between the Genomes of Adult Philadelphia Positive ALL and the Lymphoid Blast Transformation of CML

Por Grace, Colin, Nacheva, Elisabeth P.
Publicado em 2012

dMM-PBSA: A New HADDOCK Scoring Function for Protein-Peptide Docking

Por Spiliotopoulos, Dimitrios, Kastritis, Panagiotis L., Melquiond, Adrien S. J., Bonvin, Alexandre M. J. J., Musco, Giovanna, Rocchia, Walter, Spitaleri, Andrea
Publicado no Front Mol Biosci (2016)

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy

Por Qin, L, Smith, B D, Tsai, H-L, Yaghi, N K, Neela, P H, Moake, M, Fu, J, Kasamon, YL, Prince, G T, Goswami, M, Rosner, G L, Levitsky, H I, Hourigan, C S
Publicado em 2013

Gait Shear and Plantar Pressure Monitoring: A Non-Invasive OFS Based Solution for e-Health Architectures

Por Cátia Tavares, M. Fátima Domingues, Anselmo Frizera-Neto, Tiago Leite, Cátia Leitão, Nélia Alberto, Carlos Marques, Ayman Radwan, Eduardo Rocon, Paulo André, Paulo Antunes
Publicado em 2018-04-01

Management of Chronic Myeloid Leukemia in Advanced Phase

Por Bonifacio, Massimiliano, Stagno, Fabio, Scaffidi, Luigi, Krampera, Mauro, Di Raimondo, Francesco
Publicado no Front Oncol (2019)